Affecting Patent Protection – Notification of Mutually Agreed Solution”, WTO, WT/DS199/4, G/L/454, IP/D/23/Add.1 19 July 2001.
https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009DP.aspx?language=E&CatalogueIdList=34253&CurrentCatalogueIdIndex=0&FullTextSearch=, last visited: 10/09/2014.
173 . Roche Pharmaceutical company.
174 . VIREAD (tenofovir disoproxil fumarate).
175 . Essential Inventions, Inc.
176 . GLEEVEC (Imatinib Mesylate).
177. http://www.essentialinventions.org/drug/imatinibmesylate/ei12172004.pdf, last visited: 10/10/2014.
178 . COMBIVIR (lamivudine and zidovudine).
179 . James Packard Love, “Recent examples of the use of compulsory licenses on patents”. Knowledge Ecology International, KEI Research Note 2, 2007, P.14.
http://www.keionline.org/misc-docs/recent_cls_8mar07.pdf. , last visited: 10/11/2014.
180 . Abbott Laboratories Pharmaceutical company
181 . ESKE GROUP S.A.
182 . Cipla
183 . http://www.ip-watch.org/2010/04/22/ecuador-grants-first-compulsory-licence-for-hivaids-drug/, last visited: 10/08/2014.
184 . http://www.cptech.org/ip/health/cl/Ghana.png>, last visited: 10/12/2014.
185 . Lamivudine.
186 . Nevirapine.
187 . Stavudine.

مطلب مرتبط :   پایان نامه رایگان درموردثبت اختراعات، حق ثبت اختراع، کشورهای درحال توسعه، دادرسی غیابی
دسته بندی : پایان نامه ها

دیدگاهتان را بنویسید